For patients with "good-risk" ductal carcinoma in situ (DCIS) who underwent breast-conserving surgery and did not receive ...

The trial explores how Apple smartwatches can help tailor daily blood thinner use for patients with atrial fibrillation.

OSF Cancer Institute is one of the chosen few participants in an exciting new cancer treatment trial program. The founder of ...

RevBio Receives Both FDA Approval to Expand its Clinical Trial and CMS Reimbursement for its Regenerative Bone Adhesive for ...

Creating contingency plans against geopolitical uncertainty was a key theme at the 2024 Outsourcing in Clinical Trials and ...

BNT23001, a sublingual formulation of cladribine, will be tested in a pilot clinical trial in 2025 comparing it to MS ...

Discover key challenges in clinical trial design and learn how the right software can significantly boost the likelihood of ...

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States, whose ...

The trial (NCT06207370) evaluates tafenoquine combined with standard treatment for babesiosis, addressing a critical unmet ...

After a lucrative IPO in September, Richmond-based BioAge is seeing its biotech fortunes shift with its stock falling over 70 ...

Theradaptive announced this week that it received FDA approval to expand its clinical trial for OsteoAdapt SP.